Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2026-03-02 @ 7:43 AM
Study NCT ID:
NCT03311295
Status:
TERMINATED
Last Update Posted:
2021-04-28
First Post:
2017-10-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MitrAl ValvE RepaIr Clinical Trial (MAVERIC Trial) - United States
Sponsor:
Mvrx, Inc.
Organization:
Study Overview
Official Title:
MitrAl ValvE RepaIr Clinical Trial (MAVERIC Trial) - United States
Status:
TERMINATED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lagging enrollment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MAVERIC US
Brief Summary:
The objective of the study is to evaluate the safety and feasibility of the ARTO System in patients with mitral valve regurgitation (MR) associated with congestive heart failure (CHF).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
True
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: